Active/Completed Active GrantsCompleted Grants PI Name Sort descending PI Organization Title Grant Number Program Official Santomasso, Bianca Denise Sloan-Kettering Inst Can Research United States Comprehensive Molecular and Clinical Characterization of Acute and Chronic Neurotoxicity Following CAR-T Cell Therapy 5R01CA293922-02 Monica Epstein, B.S.N., RN, OCN Santos-Reyes, Luis Javier Comprehensive Cancer Center/ Univ/Pr United States Puerto Rico NCI Community Oncology Research Program (Puerto Rico NCORP) 3UG1CA189862-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H. Santos-Reyes, Luis Javier Comprehensive Cancer Center/ Univ/Pr United States Puerto Rico NCI Community Oncology Research Program (Puerto Rico NCORP) 3UG1CA189862-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H. Saphner, Thomas J Aurora Health Care, Inc. United States Aurora NCORP Community Site 3UG1CA190140-11S1 Vanessa A. White, M.P.H. Saphner, Thomas J Aurora Health Care, Inc. United States Aurora NCORP Community Site 3UG1CA190140-11S1 Vanessa A. White, M.P.H. Schallenkamp, John M. Montana Cancer Consortium United States Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming 3UG1CA189872-11S1 Vanessa A. White, M.P.H. Schallenkamp, John M. Montana Cancer Consortium United States Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming 3UG1CA189872-11S1 Vanessa A. White, M.P.H. Schaverien, Mark V University Of Tx Md Anderson Can Ctr United States Lymphedema Prevention Through Immediate Lymphatic Reconstruction 5R01CA292908-02 Brandy Heckman-Stoddard, Ph.D., M.P.H. Schaverien, Mark V University Of Tx Md Anderson Can Ctr United States Lymphedema Prevention Through Immediate Lymphatic Reconstruction 5R01CA292908-02 Brandy Heckman-Stoddard, Ph.D., M.P.H. Sedrak, Mina S University Of California Los Angeles United States Targeting Senescence to Mitigate Chemotherapy-induced Functional Decline 5R01CA280088-03 Goli Samimi, Ph.D., M.P.H. Sedrak, Mina S University Of California Los Angeles United States Targeting Senescence to Mitigate Chemotherapy-induced Functional Decline 5R01CA280088-03 Goli Samimi, Ph.D., M.P.H. Shelby, Rebecca A Duke University United States Improving outcomes for women experiencing premature or early menopause after cancer: development and pilot testing of a novel intervention 1R21CA301298-01 Goli Samimi, Ph.D., M.P.H. Shelby, Rebecca A Duke University United States Improving outcomes for women experiencing premature or early menopause after cancer: development and pilot testing of a novel intervention 1R21CA301298-01 Goli Samimi, Ph.D., M.P.H. Shiozawa, Yusuke Wake Forest University Health Sciences United States Contribution of cutaneous neuro-immune interactions to chemotherapy-induced peripheral neuropathy 5R21CA297068-02 Rachel Altshuler, Ph.D. Shiozawa, Yusuke Wake Forest University Health Sciences United States Contribution of cutaneous neuro-immune interactions to chemotherapy-induced peripheral neuropathy 5R21CA297068-02 Rachel Altshuler, Ph.D. Pagination « First First page ‹ Previous Previous page … 20 21 22 23 … Next › Next page Last » Last page
